Comera Life Sciences Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $136.31K Down From $234.92K YoY
Comera Life Sciences Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $136.31K Down From $234.92K YoY
Comera Life Sciences第三季度每股收益为0.10美元，高于同比0.20美元，销售额从同比的234.92万美元下降13.631万美元
Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.10) per share. This is a 50 percent increase over losses of $(0.20) per share from the same period last year. The company reported $136.31 thousand in sales this quarter. This is a 41.98 percent decrease over sales of $234.92 thousand the same period last year.
Comera Life Sciences（纳斯达克股票代码：CMRA）公布季度每股亏损0.10美元。这比去年同期每股亏损0.20美元（0.20美元）增加了50％。该公司报告本季度销售额为136,310美元。这比去年同期的234,920美元的销售额下降了41.98％。